Neuromuscular Disorders tests in Dubai & UAE

Compare available Neuromuscular Disorders tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

2,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Neuromuscular Disorders test prices

Showing 1–14 of 14 matching tests.

Neuromuscular Disorders diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-5225 ANO5 Gene Miyoshi Muscular Dystrophy Type 3 Genetic Test This test detects pathogenic variants in the ANO5 gene to confirm Miyoshi muscular dystrophy type 3 and related ANO5‑associated myopathies.	Peripheral Whole Blood (5–10 mL in EDTA)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ANO5 gene", "Single nucleotide variants", "Indels", "Copy number changes"] Parameters [] Preparation ["Joint consent from both parents or a legal guardian required for individuals under 18 years", "Reschedule if patient received a whole blood transfusion in the preceding 14 days"] Indications ["Individuals with progressive distal leg muscle weakness, calf atrophy, and highly elevated creatine kinase levels suggestive of Miyoshi myopathy", "At-risk family members seeking predictive or carrier testing", "Couples planning a family who wish to understand recurrence risk"] Measurement technique Confirm with laboratory Codes LOINC: 94051-0 ICD-10: G71.0 Clinical summary This test detects pathogenic variants in the ANO5 gene to confirm Miyoshi muscular dystrophy type 3 and related ANO5‑associated myopathies.
TEST-4805 CAV3 Genetic Testing (Limb-Girdle Muscular Dystrophy Type 1C) Test This test identifies pathogenic variants in the CAV3 gene, confirming a diagnosis of Limb-Girdle Muscular Dystrophy Type 1C (LGMD1C).	Peripheral blood (EDTA whole blood), extracted DNA (≥2µg), or dried blood spot on FTA card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CAV3 gene", "Single nucleotide variants", "Small indels", "Copy number alterations"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Suspected Limb-Girdle Muscular Dystrophy Type 1C (LGMD1C)", "Family history of LGMD1C", "Need for definitive molecular diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 88861-4 ICD-10: G71.0 Clinical summary This test identifies pathogenic variants in the CAV3 gene, confirming a diagnosis of Limb-Girdle Muscular Dystrophy Type 1C (LGMD1C).
TEST-3959 CCDC78 Gene Centronuclear Myopathy Type 4 Genetic Test This test evaluates the CCDC78 gene for pathogenic variants associated with autosomal recessive centronuclear myopathy type 4.	Peripheral whole blood (EDTA tube)	21–28 days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CCDC78 gene"] Parameters [] Preparation ["Do not discontinue prescribed medication without consulting your doctor."] Indications ["Clinical suspicion of congenital myopathy", "Autosomal recessive centronuclear myopathy type 4"] Measurement technique Confirm with laboratory Codes LOINC: 97996-0 ICD-10: G71.2, G71.20 Clinical summary This test evaluates the CCDC78 gene for pathogenic variants associated with autosomal recessive centronuclear myopathy type 4.
TEST-5301 CFL2 Gene Nemaline Myopathy Type 7 Genetic Test This test evaluates the CFL2 gene for mutations associated with Nemaline Myopathy Type 7.	Peripheral whole blood (EDTA tube)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CFL2 gene sequence variants"] Parameters [] Preparation [] Indications ["Suspected Nemaline Myopathy Type 7", "Family history of Nemaline Myopathy Type 7", "Reproductive planning"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: G71.2 Clinical summary This test evaluates the CFL2 gene for mutations associated with Nemaline Myopathy Type 7.
TEST-5269 CRYAB Gene Myopathy (Myofibrillar, Fatal Infantile Hypertrophy, Alpha-B Crystallin‑Related) Genetic Test This test evaluates the CRYAB gene for pathogenic variants associated with myofibrillar myopathy and fatal infantile hypertrophic cardiomyopathy.	Whole blood (EDTA), extracted genomic DNA, or dried blood spot (FTA card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CRYAB gene sequence", "Pathogenic variants in CRYAB"] Parameters [{"name": "Analytical Sensitivity", "reference_range": "99.9%"}, {"name": "Target Coverage", "reference_range": "100% coding region + splice junctions"}] Preparation ["Do not discontinue prescribed cardiac, anticonvulsant, or respiratory medication unless directed by a physician."] Indications ["Suspected CRYAB-related myopathy", "Suspected CRYAB-related cardiomyopathy", "Family history of CRYAB-related disorders"] Measurement technique Confirm with laboratory Codes LOINC: 94041-1 ICD-10: G71.0 Clinical summary This test evaluates the CRYAB gene for pathogenic variants associated with myofibrillar myopathy and fatal infantile hypertrophic cardiomyopathy.
TEST-5441 DES Gene (Desmin) Neurogenic Scapuloperoneal Syndrome, Kaeser Type, Genetic Test This genetic test identifies pathogenic variants within the DES gene, which are responsible for causing neurogenic scapuloperoneal syndrome, Kaeser type.	Whole Blood (EDTA) or Dried Blood Spot (FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the DES gene", "Copy number variations (CNVs) in the DES gene"] Parameters [] Preparation ["No fasting required", "Pre-test genetic counseling is mandatory"] Indications ["Clinical suspicion of neurogenic scapuloperoneal syndrome, Kaeser type", "Family history of scapuloperoneal syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: G71.0 Clinical summary This genetic test identifies pathogenic variants within the DES gene, which are responsible for causing neurogenic scapuloperoneal syndrome, Kaeser type.
TEST-4428 FKTN Gene NGS Test for Fukuyama Congenital Muscular Dystrophy This test evaluates the entire FKTN gene for pathogenic variants associated with Fukuyama Congenital Muscular Dystrophy (FCMD). It uses Next Generation Sequencing (NGS) for compreh...	Peripheral Whole Blood	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FKTN gene sequence", "Pathogenic variants in FKTN gene"] Parameters [] Preparation ["Pre-test genetic counselling is mandatory.", "Do not discontinue prescribed medication without consulting your treating physician."] Indications ["Confirmatory diagnosis of FCMD", "Carrier screening in at-risk couples", "Family planning"] Measurement technique Confirm with laboratory Codes LOINC: 94404-1 ICD-10: G71.0 Clinical summary This test evaluates the entire FKTN gene for pathogenic variants associated with Fukuyama Congenital Muscular Dystrophy (FCMD). It uses Next Generation Sequencing (NGS) for comprehensive analysis.
TEST-5250 LARGE1 Gene Muscular Dystrophy Type 1D Genetic Test This genetic test identifies pathogenic variants in the LARGE1 gene, which are causative for Muscular Dystrophy-Dystroglycanopathy Type A, 1 (MDDGA1).	Peripheral Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the LARGE1 gene", "Copy number analysis of the LARGE1 gene"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any bleeding disorders or anticoagulant use"] Indications ["Suspected diagnosis of LARGE1-related muscular dystrophy type 1D", "Family history of muscular dystrophy", "Need for genetic counseling and family planning"] Measurement technique Confirm with laboratory Codes LOINC: 76894-7 ICD-10: G71.2 Clinical summary This genetic test identifies pathogenic variants in the LARGE1 gene, which are causative for Muscular Dystrophy-Dystroglycanopathy Type A, 1 (MDDGA1).
TEST-5716 MYOT Gene Spheroid Body Myopathy Genetic Test This test identifies pathogenic variants in the MYOT gene associated with spheroid body myopathy.	Peripheral whole blood, extracted DNA, or blood spot on FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MYOT gene", "Copy number variations in the MYOT gene"] Parameters [] Preparation [] Indications ["Suspected spheroid body myopathy", "Family history of myopathy", "Confirmation of clinical diagnosis", "Family screening"] Measurement technique Confirm with laboratory Codes LOINC: 61729-8 ICD-10: G71.09 Clinical summary This test identifies pathogenic variants in the MYOT gene associated with spheroid body myopathy.
TEST-5387 NEB Gene Nemaline Myopathy Type 2, Autosomal Recessive Genetic Test This genetic test identifies pathogenic variants in the NEB gene associated with nemaline myopathy type 2.	Whole blood, FTA card, or extracted DNA (buccal swab accepted for paediatric cases)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the NEB gene", "Single-nucleotide variants (SNVs)", "Insertions and deletions (indels)", "Copy number variations (CNVs)"] Parameters [] Preparation ["No fasting required", "Provide detailed clinical history", "Provide three-generation pedigree chart if possible"] Indications ["Suspected nemaline myopathy type 2 based on clinical presentation", "Family history of nemaline myopathy", "Need for definitive molecular diagnosis for management and genetic counselling"] Measurement technique Confirm with laboratory Codes LOINC: 76692-9 ICD-10: G71.2 Clinical summary This genetic test identifies pathogenic variants in the NEB gene associated with nemaline myopathy type 2.
TEST-5273 POMT2 Gene Genetic Test This test identifies mutations in the POMT2 gene associated with congenital muscular dystrophy-dystroglycanopathy type B2.	Whole blood (peripheral) or extracted DNA	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the POMT2 gene", "Single nucleotide variants (SNVs)", "Insertions and deletions (indels)"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any medications"] Indications ["Suspected congenital muscular dystrophy-dystroglycanopathy type B2", "Family history of related disorders", "Neurological symptoms consistent with the condition"] Measurement technique Confirm with laboratory Codes LOINC: 85915-8 ICD-10: G71.0, Z15.89, F79 Clinical summary This test identifies mutations in the POMT2 gene associated with congenital muscular dystrophy-dystroglycanopathy type B2.
TEST-4300 SYNE2 Gene Emery-Dreifuss Muscular Dystrophy Type 5 Genetic Test This genetic test identifies pathogenic variants in the SYNE2 gene associated with Emery-Dreifuss Muscular Dystrophy Type 5.	Whole Blood (Peripheral)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SYNE2 gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any relevant medications"] Indications ["Confirm clinical suspicion of EDMD5", "Guide cardiac surveillance", "Inform family planning"] Measurement technique Confirm with laboratory Codes LOINC: 88858-1 ICD-10: G71.0 Clinical summary This genetic test identifies pathogenic variants in the SYNE2 gene associated with Emery-Dreifuss Muscular Dystrophy Type 5.
TEST-5392 TPM2 Gene Nemaline Myopathy Type 4 Genetic Test This test evaluates the TPM2 gene for pathogenic variants associated with nemaline myopathy type 4.	Whole Blood, Extracted DNA, Dried Blood Spot (FTA Card)	3–4 Weeks (Rapid reporting available)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TPM2 gene", "Copy Number Variations (CNV) in the TPM2 gene"] Parameters [] Preparation [] Indications ["Clinical suspicion of nemaline myopathy type 4", "Genetic counselling prior to pregnancy", "Testing asymptomatic siblings of affected individuals"] Measurement technique Confirm with laboratory Codes LOINC: 83113-2 ICD-10: G71.23, G71.2, G71.0 Clinical summary This test evaluates the TPM2 gene for pathogenic variants associated with nemaline myopathy type 4.
TEST-5827 TTN Gene Sequencing for Tibial Muscular Dystrophy (Tardive) Test This test identifies pathogenic variants in the TTN gene associated with Tibial Muscular Dystrophy (Tardive).	Whole Blood (EDTA), Extracted DNA, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TTN gene", "Single-nucleotide variants", "Small insertions/deletions", "Splice-site mutations"] Parameters [] Preparation ["Pre-test genetic counselling session with pedigree documentation is mandatory.", "Guardian consent required for minors (< 18 years)."] Indications ["Diagnostic confirmation of Tibial Muscular Dystrophy (Tardive)", "Family risk assessment", "Cascade screening of at-risk relatives"] Measurement technique Confirm with laboratory Codes LOINC: 82151-2 ICD-10: G71.0 Clinical summary This test identifies pathogenic variants in the TTN gene associated with Tibial Muscular Dystrophy (Tardive).

Category overview

Neuromuscular Disorders: overview

Coping with progressive muscle weakness, frequent falls, or delayed motor milestones in a child requires highly specific diagnostic clarity to unlock the most effective neurological and physical care. Within our specialized neurogenetics department, testing for Neuromuscular Disorders evaluates your DNA for inherited mutations that damage the critical proteins needed for healthy muscle fiber structure and nerve communication. Utilizing cutting-edge diagnostic technology, this vital molecular screening helps confirm conditions like spinal muscular atrophy (SMA) or congenital myopathies, providing the definitive data needed to safely guide personalized physical therapy, proactive cardiac and respiratory monitoring, and targeted genetic therapies where available. Recognized for sensitive neuromuscular diagnostics among premier diagnostic labs in Dubai and the UAE, DNA Labs ensures absolute patient confidentiality, uncompromising diagnostic accuracy, and prompt turnaround times. Take control of your neuromuscular health—book your neuromuscular disorders testing in UAE, arrange a secure clinical sample collection, or reach out to our dedicated medical team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.